Posts

Showing posts with the label Customer Development

Customer-centric Approach in Selling – Asrar Qureshi’s Blog Post #1078

Image
Customer-centric Approach in Selling – Asrar Qureshi’s Blog Post #1078 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1078 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Pavel Danilyuk Credit: Gustavo Fring Preamble For decades, businesses have followed a simple yet effective formula: create a product, find customers, and persuade them to buy based on price, features, and perceived value. This traditional “product selling” playbook, while effective in stable markets, is increasingly being challenged by rapid technological advancements, shifting consumer expectations, and market disruptions. In today's business environment, a purely transactional approach is no longer sustainable. Instead, companies must pivot towards value-driven, relationship-based, and solution-oriented models to stay competitive. My partic...

Entrepreneurship within the Pharma Industry – Part 1 – Asrar Qureshi’s Blog Post #700

Image
Entrepreneurship within the Pharma Industry – Part 1 – Asrar Qureshi’s Blog Post #700 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #700 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Genetics Pharmaceuticals HiQ Pharmaceuticals Entrepreneurship is a buzzword these days. There are stories upon stories of people making it big in the market, from nothing to millions in a matter of weeks and months. These stories are true; however, it is equally true that 9 out of 10 startups do not go beyond the first year. There are reasons for such high attrition rate, and we shall discuss these in appropriate context. I shall focus on entrepreneurship as it evolved in the Pharma Industry in Pakistan. I shall prefer not to go into the long history...

Pakistan Pharma Industry SWOT – Part 12 – Asrar Qureshi’s Blog Post #603

Image
Pakistan Pharma Industry SWOT – Part 12 – Asrar Qureshi’s Blog Post #603 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #603 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Opening Note February 2022 marks my completing 47 years of working in Pharma Industry. Allah be praised. I am still working. The first half of my working career was spent in Multinational companies, and the latter half in the Local Pharma, making me well-versed with both innovators and generics markets. I also had the opportunity to work in business as well as operations.  My journey of near half century is also the journey of Pharma Industry in Pakistan. Great changes have occurred in this time and a lot could be written about it. In my blogs, which were started ...

Post COVID Strategies – Part III – Blog Post #364 by Asrar Qureshi

Image
Post COVID Strategies – Part III – Blog Post #364 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #364. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Continued from Previous…… Strategy as a common driving force is the next topic in sequence. Pharma business is certainly not one unit; it is a lot of individual units each having their own business strategies. We therefore cannot talk about a single one or a set of strategies. I still believe that the Local Pharma Industry under PPMA should show some form of unified strategy, like their multinational counterparts do under Pharma Bureau and the OICC (Overseas Investors Chamber of Commerce). The MNCs do business separately but watch their interests together. Local P...

Pharmaceutical Marketing Practices in Pakistan Part II – Blog Post #319 by Asrar Qureshi

Image
Pharmaceutical Marketing Practices in Pakistan Part II – Blog Post #319 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #319 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here . Let us deal with the question of Ethics first, before we go further. The dictionary definition of Unethical says: -        Lacking moral principles, not adhering to proper rules of conduct -        Not in accordance with the standards of a profession Business definition in my view should be: -        Getting undue advantage over competitors through misuse of resources -        Disrupting the rules of level...

The Case of ‘Ja’alee’ (spurious) Drugs – Pharma Marketing - Blog Post #286 by Asrar Qureshi

Image
Dear Colleagues!  This is Pharma Veterans Blog Post #286. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of Community at large. Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from Previous…… Pharmaceutical companies have always relied on Marketing to introduce their drugs. Over time, marketing strategies and plans help to build big brands and contribute to the success and profitability of the company. Following is a list of five top selling drugs worldwide based on last year sales. 1.      Humira (adalimumab) – by AbbVie – for Autoimmune Diseases – Sales 19.9 Billion USD 2.      Eliquis (apixaban) – by BMS/Pfizer – for cardiovascular Problem – Sales 9.8 Billion USD 3.  ...